As CEO of MolecularMD, Dan guided the company from inception through growth to a $42M strategic acquisition by ICON PLC, establishing it as a leader in diagnostics for development of precision medicines.  He also founded Protein Solutions, building the business into a global supplier of protein analysis instrumentation, currently marketed by Waters Corporation. His leadership roles with Hemodyne, Upstate Biotechnology, Tasso, and iRepertoire further demonstrate his ability to commercialize breakthrough technologies and secure strategic partnerships.

While embracing the urgency and culture of startup environments, Dan takes a pragmatic approach to matching innovation with validated market applications. He is a customer-centric leader, known for aligning external market signals with enterprise vision and strategy to unlock business value. Dan applies an agile, hands-on approach to achieve near-term objectives while orchestrating sustainable frameworks for long-term growth.

Today, as Managing Director and Founder of The Playbook, Dan partners with health science startups to transition from founder-led sales to scalable, validated commercial capacity. 

Dan holds a B.A. in Economics from the University of Virginia, an MBA from William & Mary’s Raymond A. Mason School of Business, and has completed advanced coursework at MIT in drug and medical device development. In addition to his executive leadership, he actively supports nonprofit organizations through board service and fundraising initiatives that advance high-impact missions.